Enhanced Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Type 1-Infected Patients

Podobne zapisy

• Salivary Secretory Leukocyte Protease Inhibitor and Oral Candidiasis in Human Immunodeficiency Virus Type 1-Infected Persons
  od: Chattopadhyay, Amit, i wsp.
  Wydane: (2004)
• Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection
  od: Skeate, Joseph G., i wsp.
  Wydane: (2016)
• Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk
  od: Farquhar, Carey, i wsp.
  Wydane: (2002)
• Estimation and Comparison of Salivary Secretory Leukocyte Protease Inhibitor in Human Immunodeficiency Virus Patients and Healthy Individuals
  od: Pushpanshu, Kumar, i wsp.
  Wydane: (2014)
• Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers
  od: Hocini, Hakim, i wsp.
  Wydane: (2000)